Invicro, LLC is a leading provider of quantitative biomarkers, advanced analytics, and imaging solutions that enhance the discovery and development of life-changing drugs. With expertise spanning multiple therapeutic areas including oncology, central nervous system, and respiratory, Invicro serves top pharma and biotech companies from molecular discovery through late-phase clinical trials.
Through their comprehensive capabilities in preclinical imaging, early clinical imaging, clinical imaging core lab, pathology, radiochemistry, and image analysis software, Invicro manages thousands of research and clinical trials, processes millions of DICOM images, and offers unmatched solutions in PSMA-PET and radiopharmaceutical therapy. Their IQ Analytics Platform enables the design, capture, analysis, and management of data, providing valuable insights in early drug discovery and supporting all phases of drug development.
Generated from the website
